New study explores how pregnancy during breast cancer treatment affects Long-Term Well-Being
NCT ID NCT07191496
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at the quality of life of women who were pregnant while undergoing breast cancer treatment. Researchers used questionnaires to measure physical, emotional, and social well-being. The goal was to better understand the unique challenges these women face. However, the study was terminated early and included only 30 participants, so findings are limited.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better support women facing breast cancer during pregnancy by understanding their long-term well-being.
- What could go wrong
- The study was terminated early and enrolled only 30 participants, so results may be limited and not apply to all women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
30 people
The number who actually took part.
- Started
-
Oct 2025
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
MD Anderson Cancer Center
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Eligibility Criteria * Female, any current age and any age at diagnosis * Documented diagnosis of breast cancer during pregnancy * Documentation of receiving chemotherapy during pregnancy * Alive with no evidence of disease at time of recruitment * Able to reach and speak English Exclusion Criteria * Any woman who delayed and received their chemotherapy after delivery. * Any woman who was diagnosed with breast cancer before or after their pregnancy. * Any woman whom there is documentation of inability to provide consent in the medical record
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?